
Management Change10 Aug 2026, 04:10 pm
Mankind Pharma Appoints Anish Vanraj Bafna as Independent Director
AI Summary
Mankind Pharma Ltd announced the appointment of Mr. Anish Vanraj Bafna as an Additional Director, designated as a Non-Executive Independent Director, effective August 10, 2026. This appointment is subject to member approval via postal ballot. Mr. Bafna brings over 30 years of experience in the healthcare and medical devices sector, including significant leadership roles at Healthium Medtech Limited and Baxter International. He is not related to any existing directors or key management personnel and meets independence criteria. The board meeting where this was approved commenced at 3:30 p.m. IST and concluded at 3:45 p.m. IST.
Key Highlights
- Anish Vanraj Bafna appointed as Non-Executive Independent Director.
- Appointment effective August 10, 2026, pending member approval.
- Bafna has over 30 years of experience in healthcare and medical devices.
- He previously led Healthium Medtech and held roles at Baxter International.
- Bafna is independent and not related to current management.
Price Impact
More from MANKIND